{"id":22619,"date":"2024-01-26T08:42:36","date_gmt":"2024-01-26T07:42:36","guid":{"rendered":"https:\/\/k2info.w.uib.no\/?p=22619"},"modified":"2024-01-26T12:05:40","modified_gmt":"2024-01-26T11:05:40","slug":"vestlandslegen-kolleger-tesfaye-madebo","status":"publish","type":"post","link":"https:\/\/k2info.w.uib.no\/en\/2024\/01\/26\/vestlandslegen-kolleger-tesfaye-madebo\/","title":{"rendered":"[:no]Vestlandslegen kolleger \u2013 Tesfaye Madebo[:en]Vestlandslegen Colleagues \u2013 Tesfaye Madebo[:]"},"content":{"rendered":"<p>[:no]<strong>Hei kj\u00e6re kollegaer i K2,<\/strong><\/p>\n<p>Jeg er Tesfaye Madebo og jobber son spesialist i lungemedisin og indremedisin. Jeg arbeider som overlege ved Lungeavdeling ved SUS og i bistilling som f\u00f8rsteamanuesis ved K2 (Vestlandslegen, UIB)<\/p>\n<div id=\"attachment_22620\" style=\"width: 277px\" class=\"wp-caption alignnone\"><a href=\"https:\/\/k2info.w.uib.no\/files\/2024\/01\/Picture1.png\"><img loading=\"lazy\" decoding=\"async\" aria-describedby=\"caption-attachment-22620\" class=\"wp-image-22620\" src=\"https:\/\/k2info.w.uib.no\/files\/2024\/01\/Picture1.png\" alt=\"\" width=\"267\" height=\"352\" \/><\/a><p id=\"caption-attachment-22620\" class=\"wp-caption-text\">Foto.:\/ill Privat<\/p><\/div>\n<p>I klinikken jobber jeg mest innen lungekreft (diagnostikk og behandling) og en rekke andre lungesykdommer b\u00e5de p\u00e5 post og poliklinikk og i vakt sammenheng. \u00a0P\u00e5 noen av hovedproblemstillingene innen lungefaget har vi samarbeid prosjekter med kollegaer fra UiB (innen lungekreft (samvalg, OL Margrethe) og lungesykdommer i ATLAS4LAR gruppe (professor Lars Thore) har vi p\u00e5g\u00e5ende kliniske studier.Som en del av nasjonal lungekreft nettverket samarbeider vi med andre store sykehusene i Norge f. eks OUS (DART, SOLUCOM, MIMILUC og LUNGEVAC studier) og ved St. Olavs Hospital (TRIPLEX og THORA II), hovedsakelig klinisk fase II og III legemiddelfors\u00f8k studier. Selv om det har v\u00e6rt imponerende resultater de siste \u00e5rene innen nye behandlingsformer, som immunoterapi og biologisk behandling for lungekreft, opplever mange pasienter fortsatt progresjon eller tilbakefall. Det er avgj\u00f8rende \u00e5 \u00f8ke v\u00e5r forst\u00e5else av den underliggende biologien som p\u00e5virker responsene og resistensen. Det p\u00e5g\u00e5r mange spennende studier i Norge som SUS er en del av for \u00e5 identifisere prediktive og prognostiske mark\u00f8rer, med h\u00e5p om \u00e5 utvikle bedre behandlingsmuligheter over tid.<\/p>\n<p>I tillegg til mitt kliniske arbeid og forskning, er jeg aktivt involvert i studentundervisning innen lungefaget for medisinstudenter, yngre leger og kreftsykepleiere. Jeg fungerer ogs\u00e5 som co-veileder for en Ph.d.-student. Jeg setter stor pris p\u00e5 muligheten til \u00e5 bidra til oppbyggingen av medisinstudiet ved SUS som en del av Vestlandslegen\/UiB, som ikke bare er spennende, men ogs\u00e5 utgj\u00f8r et betydelig bidrag til det lokale SUS milj\u00f8et. Det er et stort privilegium for meg \u00e5 forene klinisk praksis, forskning og undervisning i mitt yrke (n\u00e5 i regi UiB).<\/p>\n<p><strong>Hva liker du \u00e5 jobbe med p\u00e5 K2?<br \/>\n<\/strong>Jeg starter \u00e5 jobbe offisielt med medisin studenter fra mai 2023 som er relativt kort tid i jobben som f\u00f8rsteamanuensis. Jeg liker veldig godt \u00e5 jobbe p\u00e5 Vestlandslegen\/ K2 fordi gjennom klinisk arbeid, forskning og undervisninger som en del en store milj\u00f8 har jeg stor mulighet til \u00e5 utvikle meg faglig. \u00a0Jeg kontinuerlig tilegner meg ny innsikt gjennom samarbeid med kollegaer, forskningssamarbeidspartnere p\u00e5 tvers av spesialiteter og engasjerte studenter. Denne dynamiske interaksjonen gir meg ikke bare energi, men ogs\u00e5 m\u00e5l \u00e5 strekke meg etter. \u00c5 samarbeide p\u00e5 tvers av fagomr\u00e5der er s\u00e6rlig berikende, og gir meg muligheten til \u00e5 utforske ulike perspektiver.<br \/>\nI tillegg gir arbeidet meg sjansen til \u00e5 m\u00f8te kollegaer i forskjellige stadier av deres karrierer, b\u00e5de p\u00e5 tvers av fagomr\u00e5der og institusjoner. Denne mangfoldige interaksjonen bidrar til en bredere forst\u00e5else av fagfeltet mitt. Arbeidet p\u00e5 vestlandslegen\/ K2 gir meg ogs\u00e5 tilgang til kurs innen pedagogikk og veiledning, noe som ikke bare beriker min faglige kompetanse, men ogs\u00e5 har en positiv innvirkning p\u00e5 min personlige utvikling. Gjennom undervisningen m\u00f8ter jeg dyktige og nysgjerrige studenter, og det er en glede \u00e5 kunne bidra til at de tilegner seg kunnskap om lunge- og indremedisinfaget. \u00c5 veilede og undervise medisinstudenter og yngre leger gir meg en stor tilfredsstillelse. Det er inspirerende \u00e5 observere mine kollegaers faglige og kliniske kompetanse vokse og utvikle seg. Arbeidsmilj\u00f8et er behagelig, og mine kollegaer, b\u00e5de innen vitenskapelige og administrative stillinger, opplever jeg som kompetente, hjelpsomme og engasjerte. Dette skaper en positiv forventning og entusiasme for hver arbeidsdag.<\/p>\n<p>Tesfaye Madebo<br \/>\nOverlege v\/ SUS<br \/>\n1.amanuensis v\/UiB[:en]<\/p>\n<div class=\"w-full text-token-text-primary\" data-testid=\"conversation-turn-5\">\n<div class=\"px-4 py-2 justify-center text-base md:gap-6 m-auto\">\n<div class=\"flex flex-1 text-base mx-auto gap-3 md:px-5 lg:px-1 xl:px-5 md:max-w-3xl lg:max-w-[40rem] xl:max-w-[48rem] group final-completion\">\n<div class=\"relative flex w-full flex-col lg:w-[calc(100%-115px)] agent-turn\">\n<div class=\"flex-col gap-1 md:gap-3\">\n<div class=\"flex flex-grow flex-col max-w-full\">\n<div class=\"min-h-[20px] text-message flex flex-col items-start gap-3 whitespace-pre-wrap break-words [.text-message+&amp;]:mt-5 overflow-x-auto\" data-message-author-role=\"assistant\" data-message-id=\"ba8d7324-9195-438f-a9c0-191a5190b360\">\n<div class=\"markdown prose w-full break-words dark:prose-invert light\">\n<p><strong>Hello dear colleagues at K2,<\/strong><\/p>\n<p>I am Tesfaye Madebo, working as a specialist in pulmonary and internal medicine. I am an attending physician at the Lung Department at SUS and hold a concurrent position as an associate professor at K2 (Vestlandslegen, UIB).<br \/>\nIn my clinical practice, I mainly focus on lung cancer (diagnosis and treatment) and various other pulmonary diseases, both in inpatient and outpatient settings, as well as during on-call shifts. We have ongoing collaborative projects with colleagues from UiB in the field of lung cancer (shared decision-making, OL Margrethe), and within the ATLAS4LAR group (Professor Lars Thore), we are conducting clinical studies on lung diseases. As part of the national lung cancer network, we collaborate with other major hospitals in Norway, such as OUS (DART, SOLUCOM, MIMILUC, and LUNGEVAC studies) and St. Olavs Hospital (TRIPLEX and THORA II), mainly in clinical phase II and III drug trials. Despite impressive results in recent years with new treatment modalities like immunotherapy and biological treatment for lung cancer, many patients still experience progression or relapse. It is crucial to increase our understanding of the underlying biology influencing responses and resistance. Numerous exciting studies are underway in Norway, with SUS actively participating, aiming to identify predictive and prognostic markers for the development of better treatment options over time.<\/p>\n<div id=\"attachment_22620\" style=\"width: 305px\" class=\"wp-caption alignnone\"><a href=\"https:\/\/k2info.w.uib.no\/files\/2024\/01\/Picture1.png\"><img loading=\"lazy\" decoding=\"async\" aria-describedby=\"caption-attachment-22620\" class=\" wp-image-22620\" src=\"https:\/\/k2info.w.uib.no\/files\/2024\/01\/Picture1.png\" alt=\"\" width=\"295\" height=\"389\" \/><\/a><p id=\"caption-attachment-22620\" class=\"wp-caption-text\">Photo: \/ Private<\/p><\/div>\n<p>In addition to my clinical work and research, I am actively involved in teaching students in pulmonary medicine, including medical students, junior doctors, and oncology nurses. I also serve as a co-supervisor for a Ph.D. student. I greatly appreciate the opportunity to contribute to the development of the medical program at SUS as part of Vestlandslegen\/UiB. It not only provides an exciting experience but also makes a significant contribution to the local SUS environment. It is a great privilege for me to integrate clinical practice, research, and teaching in my profession (now under UiB).<\/p>\n<p><strong>What do i enjoy working on at K2?<br \/>\n<\/strong>I officially start working with medical students from May 2023, which is a relatively short time into my position as an associate professor. I enjoy working at Vestlandslegen\/K2 because, through clinical work, research, and teaching as part of a large environment, I have significant opportunities for professional development. I continuously gain new insights through collaboration with colleagues, research partners across specialties, and engaged students. This dynamic interaction not only energizes me but also provides goals to strive for. Collaborating across disciplines is particularly enriching, offering me the opportunity to explore different perspectives.<br \/>\nAdditionally, the work gives me a chance to meet colleagues at various stages of their careers, both across disciplines and institutions. This diverse interaction contributes to a broader understanding of my field. Working at Vestlandslegen\/K2 also provides access to courses in pedagogy and mentoring, enriching not only my professional competence but also positively impacting my personal development. Through teaching, I encounter skilled and curious students, and it is a pleasure to contribute to their knowledge in the field of pulmonary and internal medicine. Guiding and teaching medical students and junior doctors brings me great satisfaction. It is inspiring to observe the growth and development of my colleagues&#8217; professional and clinical competence. The working environment is pleasant, and my colleagues, both in scientific and administrative positions, are competent, helpful, and engaged. This creates a positive expectation and enthusiasm for each working day.<\/p>\n<p>Tesfaye Madebo<br \/>\nAttending Physician at SUS<br \/>\nAssociate Professor at UiB<\/p>\n<\/div>\n<\/div>\n<\/div>\n<div class=\"mt-1 flex justify-start gap-3 empty:hidden\">\n<div class=\"text-gray-400 flex self-end lg:self-center justify-center lg:justify-start mt-0 -ml-1 visible\">\n<p>&nbsp;<\/p>\n<div class=\"flex\"><\/div>\n<div class=\"flex items-center gap-1.5 text-xs\"><\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<div class=\"mx-auto\">\n<div data-projection-id=\"46\">\n<div class=\"mx-auto mt-2 inline-flex rounded-xl border border-gray-100 dark:border-gray-700\"><\/div>\n<\/div>\n<\/div>\n<p>[:]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>[:no]Hei kj\u00e6re kollegaer i K2, Jeg er Tesfaye Madebo og jobber son spesialist i lungemedisin og indremedisin. Jeg arbeider som overlege ved Lungeavdeling ved SUS og i bistilling som f\u00f8rsteamanuesis ved K2 (Vestlandslegen, UIB) I klinikken jobber jeg mest innen&hellip;<\/p>\n<p class=\"more-link-p\"><a class=\"more-link\" href=\"https:\/\/k2info.w.uib.no\/en\/2024\/01\/26\/vestlandslegen-kolleger-tesfaye-madebo\/\">Read more &rarr;<\/a><\/p>\n","protected":false},"author":5096,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[44,201668],"tags":[],"class_list":["post-22619","post","type-post","status-publish","format-standard","hentry","category-nyheter","category-vestlandslegen"],"_links":{"self":[{"href":"https:\/\/k2info.w.uib.no\/en\/wp-json\/wp\/v2\/posts\/22619","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/k2info.w.uib.no\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/k2info.w.uib.no\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/k2info.w.uib.no\/en\/wp-json\/wp\/v2\/users\/5096"}],"replies":[{"embeddable":true,"href":"https:\/\/k2info.w.uib.no\/en\/wp-json\/wp\/v2\/comments?post=22619"}],"version-history":[{"count":3,"href":"https:\/\/k2info.w.uib.no\/en\/wp-json\/wp\/v2\/posts\/22619\/revisions"}],"predecessor-version":[{"id":22629,"href":"https:\/\/k2info.w.uib.no\/en\/wp-json\/wp\/v2\/posts\/22619\/revisions\/22629"}],"wp:attachment":[{"href":"https:\/\/k2info.w.uib.no\/en\/wp-json\/wp\/v2\/media?parent=22619"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/k2info.w.uib.no\/en\/wp-json\/wp\/v2\/categories?post=22619"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/k2info.w.uib.no\/en\/wp-json\/wp\/v2\/tags?post=22619"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}